We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+9%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$24.5B
AUM Growth
+$4.37B
Cap. Flow
+$2.47B
Cap. Flow %
10.08%
Top 10 Hldgs %
39.35%
Holding
397
New
164
Increased
36
Reduced
47
Closed
100

Top Buys

Rank Stock Value
1
NUAN
Nuance Communications, Inc.
NUAN
+$387M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$332M
3
NOW icon
ServiceNow
NOW
+$265M
4
NYT icon
New York Times
NYT
+$189M
5
MXIM
Maxim Integrated Products
MXIM
+$152M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$456M
2
IPHI
INPHI CORPORATION
IPHI
+$311M
3
IQV icon
IQVIA
IQV
+$278M
4
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$277M
5
EDU icon
New Oriental
EDU
+$192M

Sector Composition

Rank Sector Weight
1 Healthcare 29.51%
2 Technology 16.43%
3 Financials 13.12%
4 Communication Services 9.43%
5 Industrials 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HIG icon
126
Hartford Financial Services
HIG
$36.9B
$9.3M 0.04%
+150,000
New +$9.83M
SVRA icon
127
Savara
SVRA
$1.15B
$9.27M 0.04%
5,452,086
+1,326,209
+32% +$2.39M
QURE icon
128
uniQure
QURE
$3.36B
$9.24M 0.04%
300,000
– –
ALBO
129
DELISTED
Albireo Pharma Inc
ALBO
$8.79M 0.04%
250,000
– –
PACB icon
130
Pacific Biosciences
PACB
$420M
$8.74M 0.04%
+250,000
New +$7.27M
ARYD
131
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$8.58M 0.04%
800,000
– –
NVAX icon
132
Novavax
NVAX
$1.47B
$8.49M 0.03%
40,000
-135,000
-77% -$24.7M
PSPC.U
133
DELISTED
Post Holdings Partnering Corporation Units, each consisting of one share of Series A common stock, and one-third of one redeemable warrant
PSPC.U
$8.31M 0.03%
+800,000
New +$8.08M
MDLA
134
DELISTED
Medallia, Inc.
MDLA
$8.1M 0.03%
+240,000
New +$6.9M
LVRA
135
DELISTED
Levere Holdings Corp. Class A Ordinary Shares
LVRA
$7.82M 0.03%
+800,000
New +$7.85M
JWSM
136
DELISTED
Jaws Mustang Acquisition Corp.
JWSM
$7.81M 0.03%
+800,000
New +$7.89M
CPARU
137
DELISTED
Catalyst Partners Acquisition Corp. Unit
CPARU
$7.57M 0.03%
+753,900
New +$7.58M
YTPG
138
DELISTED
TPG Pace Beneficial II Corp.
YTPG
$7.56M 0.03%
+750,000
New +$7.57M
PANA
139
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
$7.5M 0.03%
+750,000
New +$7.51M
RACB
140
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
$7.5M 0.03%
750,000
– –
SURF
141
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$7.46M 0.03%
1,000,000
– –
VAQC
142
DELISTED
Vector Acquisition Corporation II Class A Ordinary Shares
VAQC
$7.45M 0.03%
750,000
– –
GSEV
143
DELISTED
Gores Holdings VII, Inc. Class A Common Stock
GSEV
$7.42M 0.03%
+750,000
New +$7.43M
AUR icon
144
Aurora
AUR
$12.5B
$7.41M 0.03%
+750,000
New +$7.43M
WPCB
145
DELISTED
Warburg Pincus Capital Corporation I-B
WPCB
$7.41M 0.03%
+750,000
New +$7.39M
WPCA
146
DELISTED
Warburg Pincus Capital Corporation I-A
WPCA
$7.4M 0.03%
+750,000
New +$7.45M
LBPH
147
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$7.39M 0.03%
810,500
– –
OPAL icon
148
OPAL Fuels
OPAL
$64.4M
$7.37M 0.03%
+750,000
New +$7.38M
MVLA
149
DELISTED
Movella Holdings Inc. Common Stock
MVLA
$7.35M 0.03%
+750,000
New +$7.37M
APGB
150
DELISTED
Apollo Strategic Growth Capital II
APGB
$7.3M 0.03%
+750,000
New +$7.37M
4 5
6
7 8

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q2 2021 Portfolio in Review

As of Q2 2021, Thomas Steyer held 397 positions worth $24.5B, up 22% from $20.1B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Thomas Steyer deployed $2.47B of net new capital in Q2 2021, opening 164 new positions and adding to 36 existing holdings. Its largest new stake was Nuance Communications, Inc.: 7,337,500 shares worth $399M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 36% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $456M trimmed.

  • Thomas Steyer's largest Q2 2021 buy was Nuance Communications, Inc.: 7,337,500 shares worth $399M.
  • Thomas Steyer added most to Alexion Pharmaceuticals in Q2 2021, an estimated $332M increase.
  • Thomas Steyer's biggest Q2 2021 reduction was Alphabet (Google) Class C, cutting an estimated $456M.
  • Thomas Steyer fully exited INPHI CORPORATION in Q2 2021, selling an estimated $311M.
  • Thomas Steyer's ten largest holdings make up 39% of its $24.5B portfolio in Q2 2021.
  • Thomas Steyer opened 164 new positions and closed 100 in Q2 2021.
  • Thomas Steyer's portfolio value rose 22% quarter-over-quarter to $24.5B.

Based on Farallon Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.